Neurogene Target Price

Analysts' average 12-month price target for Neurogene is $72.

Get informed when a big investor buys or sells

+ Follow

Share Price

$31.25

Average Target Price

$71.50

128.8% upside

4 analysts in the last 4 months

High: $81 | Low: $65

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-12	H.C. WainwrightMitchel Kapoor	$65	108% upside
2026-08-12	GuggenheimDebjit Chattopadhyay	$81	159.2% upside
2026-06-09	H.C. WainwrightMitchel Kapoor	$70	124% upside
2026-06-03	UBS	$70	124% upside
2026-04-28	Guggenheim	$69	120.8% upside
2025-10-02	H.C. Wainwright	$45	44% upside
2025-04-14	BMO CapitalKeith Tapper	$16	48.8% downside
2025-03-25	Robert W. BairdJoel Beatty	$38	21.6% upside
2025-03-25	H.C. WainwrightMitchell Kapoor	$50	60% upside
2024-11-20	Stifel NicolausPaul Matteis	$46	47.2% upside
2024-11-19	BMO CapitalKeith Tapper	$45	44% upside
2024-11-12	BMO CapitalKeith Tapper	$60	92% upside
2024-11-12	Stifel NicolausPaul Matteis	$60	92% upside
2024-08-12	H.C. WainwrightMitchell Kapoor	$49	56.8% upside
2024-06-26	BMO CapitalKeith Tapper	$65	108% upside
2024-06-10	Robert W. BairdJoel Beatty	$54	72.8% upside
2024-05-13	H.C. WainwrightMitchel Kapoor	$51	63.2% upside

Neurogene (NGNE) FAQ

As of the most recent data, NGNE shows a target price of $72. Scroll down for historical charts and peer comparison views.

If Neurogene moved to the average analyst target of $72, shares would be roughly 128.8% higher than $31.25. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Neurogene's earnings trajectory.

Besides this target price page, Stockcircle has Neurogene's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $72) with ownership activity and broader fundamentals.

Neurogene's target price is $72; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.